Charts Thiogenesis Therapeutics, Corp.

Stocks

Delayed Toronto S.E. 01:01:58 15/08/2026 am IST			5-day change	1st Jan Change
0.5500 ^CAD	-3.51%		0.00%	-15.38%

07/08	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
13/07	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Stock exchange

Toronto S.E. TTI 0.5500 $ -3.51% 7.15T $

Markets		Price	Change	Volumes
Toronto S.E.	TTI	0.5500CAD	-3.51%	7.15T $
Deutsche Boerse AG	Q8M	0.3160EUR	0.00%	0 €

ProRealTime Chart